These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4029198)

  • 1. Clinical significance of plasma lipid-bound sialic acid (LBSA) and carcinoembryonic antigen (CEA) in gynaecologic cancer patients.
    Tredese F; Maggino T; Salvagno L; Marchesoni D; Chizzolini M; Pattaro RF
    Eur J Gynaecol Oncol; 1985; 6(2):136-8. PubMed ID: 4029198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monitoring the course of malignant neoplasms of the genital organs in women by means of determination of blood serum level of fucose, sialic acid, CEA and AFP].
    Simm S; Markowska J; Tomaszkiewicz T; Herwichowska K; Breborowicz J
    Ginekol Pol; 1979 Dec; 50(12):1029-36. PubMed ID: 94024
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of gastric cancer by a combination of tissue polypeptide antigen (TPA), lipid-bound sialic acid (LBSA) and carcinoembryonic antigen (CEA).
    Uehara Y; Kojima O; Ikeda E; Majima T; Nishioka B; Fujita Y; Majima S
    Gastroenterol Jpn; 1984 Oct; 19(5):424-9. PubMed ID: 6519414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid bound sialic acid in cancer patients.
    Salvagno L; Ferrazzi E; Sileni VC; Maggi S; Tredese F; Bedendo C; Russo MP; Fiorentino MV; Ceriotti G
    Tumori; 1985 Apr; 71(2):127-33. PubMed ID: 4002346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preliminary evaluation of the usefulness of determination of blood serum fucose and sialic acid level in women with genital tumors].
    Simm S; Markowska J; Tomaszkiewicz T; Herwichowska K
    Ginekol Pol; 1979 Nov; 50(11):957-63. PubMed ID: 544355
    [No Abstract]   [Full Text] [Related]  

  • 6. Carcinoembryonic antigen in gynecologic patients. I. Correlation of plasma levels and tissue localization.
    Puri S; Mesa-Tejada R; Husami N; Bennett S; Richart RM; Fenogolio CM
    Gynecol Oncol; 1977 Dec; 5(4):331-7. PubMed ID: 590854
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma lipid-bound sialic acid and carcinoembryonic antigen in cancer patients.
    Dnistrian AM; Schwartz MK
    Clin Chem; 1981 Oct; 27(10):1737-9. PubMed ID: 7285326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoembryonic antigen in gynecologic patients. II. Immunohistological expression.
    Fenoglio CM; Crum CP; Pascal RR; Richart RM
    Diagn Gynecol Obstet; 1981; 3(4):291-9. PubMed ID: 7338157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical markers in gynaecological cancer.
    Farrell RJ
    Ir Med J; 1980 Aug; 73(8):285-6. PubMed ID: 6161106
    [No Abstract]   [Full Text] [Related]  

  • 10. Carcinoembryonic antigen and beta 2-microglobulin as serum tumor markers in women with genital cancer.
    Khoo SK; Daunter B; Mackay E
    Int J Gynaecol Obstet; 1979; 16(5):388-93. PubMed ID: 86469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of neopterin determination as a tumour marker in ovarian cancer.
    Szarka G; Pulay T; Csömör S; Tran-Phoung-Mai ; Schumann B
    Acta Chir Hung; 1988; 29(4):359-64. PubMed ID: 3239335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of serum lipid-bound sialic acid and carcinoembryonic antigen in patients with lung cancer].
    Zhu X
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Feb; 13(1):25-7, 61. PubMed ID: 2165867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-bound sialic acid as a tumor marker.
    Dnistrian AM; Schwartz MK
    Ann Clin Lab Sci; 1983; 13(2):137-42. PubMed ID: 6859805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of different serum tumor markers in gynecological malignancies.
    Paulick R; Caffier H; Horner G; Lang K; Filbry E
    Cancer Detect Prev; 1985; 8(1-2):115-20. PubMed ID: 4064031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of polyamine determination in monitoring malignant gynaecological tumours.
    Szarka G; Pulay T; Csömör S; Tran-Phuong-Mai ; Schumann B
    Acta Chir Hung; 1988; 29(4):365-72. PubMed ID: 3239336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum sialic acid (TSA/LSA) and carcinoembryonic antigen (CEA) levels in cancer patients undergoing radiotherapy.
    Stringou E; Chondros K; Kouvaris J; Kakari S; Papavassiliou K
    Anticancer Res; 1992; 12(1):251-5. PubMed ID: 1567173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of N-acetylneuraminic acid (NANA) in the serum of patients with gynecologic cancers].
    Schrempel A; Kürschner M
    Zentralbl Gynakol; 1985; 107(3):175-8. PubMed ID: 3984572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum sialic acid and CEA concentrations in human breast cancer.
    Hogan-Ryan A; Fennelly JJ; Jones M; Cantwell B; Duffy MJ
    Br J Cancer; 1980 Apr; 41(4):587-92. PubMed ID: 7387856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of sialic acid and carcinoembryonic antigen as monitors of tumor burden among patients with carcinoma of the ovary.
    Silver HK; Karim KA; Salinas FA; Swenerton KD
    Surg Gynecol Obstet; 1981 Aug; 153(2):209-13. PubMed ID: 7244990
    [No Abstract]   [Full Text] [Related]  

  • 20. Five tumor markers in lung cancer: significance of total and "lipid"-bound sialic acid.
    Kakari S; Stringou E; Toumbis M; Ferderigos AS; Poulaki E; Chondros K; Dema A; Kotsovoulou V; Pavlidis N
    Anticancer Res; 1991; 11(6):2107-10. PubMed ID: 1663720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.